Executive Wealth Management LLC boosted its stake in shares of Clorox Co (NYSE:CLX) by 14.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,014 shares of the company’s stock after purchasing an additional 2,867 shares during the quarter. Executive Wealth Management LLC’s holdings in Clorox were worth $3,524,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in CLX. Janus Henderson Group PLC raised its stake in Clorox by 28.4% during the 1st quarter. Janus Henderson Group PLC now owns 1,771,185 shares of the company’s stock valued at $284,204,000 after purchasing an additional 391,569 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Clorox by 21.5% in the 4th quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after buying an additional 335,835 shares in the last quarter. Martingale Asset Management L P raised its stake in shares of Clorox by 152.4% in the 1st quarter. Martingale Asset Management L P now owns 211,703 shares of the company’s stock valued at $33,971,000 after buying an additional 127,816 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Clorox by 65.4% in the 1st quarter. PNC Financial Services Group Inc. now owns 299,966 shares of the company’s stock valued at $48,133,000 after buying an additional 118,660 shares in the last quarter. Finally, Kornitzer Capital Management Inc. KS raised its stake in shares of Clorox by 41.1% in the 2nd quarter. Kornitzer Capital Management Inc. KS now owns 402,319 shares of the company’s stock valued at $61,599,000 after buying an additional 117,272 shares in the last quarter. Hedge funds and other institutional investors own 77.01% of the company’s stock.
Shares of NYSE CLX opened at $158.96 on Wednesday. The company has a market cap of $20.20 billion, a price-to-earnings ratio of 25.15, a PEG ratio of 4.98 and a beta of 0.37. The company has a quick ratio of 0.55, a current ratio of 0.91 and a debt-to-equity ratio of 4.09. Clorox Co has a 1 year low of $140.82 and a 1 year high of $167.70. The company has a 50-day simple moving average of $158.36.
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 16th. Stockholders of record on Wednesday, July 31st will be paid a $1.06 dividend. This represents a $4.24 annualized dividend and a dividend yield of 2.67%. The ex-dividend date is Tuesday, July 30th. This is a positive change from Clorox’s previous quarterly dividend of $0.96. Clorox’s dividend payout ratio (DPR) is 67.09%.
CLX has been the topic of several analyst reports. Argus lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Monday, May 20th. Citigroup set a $156.00 target price on shares of Clorox and gave the stock a “hold” rating in a report on Thursday, May 23rd. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 price objective on the stock in a report on Monday, July 29th. UBS Group increased their price objective on shares of Clorox from $110.00 to $128.00 and gave the stock a “sell” rating in a report on Friday, August 2nd. Finally, Wells Fargo & Co reissued a “hold” rating and set a $153.00 price objective on shares of Clorox in a report on Thursday, August 1st. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. Clorox currently has a consensus rating of “Hold” and a consensus price target of $154.07.
In other news, SVP Denise Garner sold 20,399 shares of the firm’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $157.61, for a total value of $3,215,086.39. Following the transaction, the senior vice president now owns 4,896 shares of the company’s stock, valued at approximately $771,658.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director A D. David Mackay sold 3,400 shares of the stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The disclosure for this sale can be found here. Insiders sold a total of 25,786 shares of company stock worth $4,054,776 in the last ninety days. Insiders own 1.40% of the company’s stock.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
See Also: What is a Call Option?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.